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ABSTRACT
Objective: To conduct a systematic review of  the literature on the prevention of  catheter-related bloodstream infections in patients on
hemodialysis. Methods: A literature search was performed in Medline, Embase, Scielo, Lilacs, and Cochrane databases for articles published
from 1990 to 2008.  Results:  Two hundred ninety- three articles were retrieved. However, only 12 studies were included in this review.
Conclusions:  Findings suggest that health care providers use several infection control measures to prevent bloodstream infections in this
patient population.
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RESUMO
Objetivo: Realizar uma revisão sistemática sobre medidas padronizadas para prevenção de infecções relacionadas a cateter em pacientes em
hemodiálise. Métodos: Foi realizada uma revisão sobre a prevenção de infecções em hemodiálise nas bases de dados Medline, Embase,
SciElo, Lilacs e Cochrane Library de estudos publicados entre os anos de 1990 e 2008. Resultados: Foram encontrados 293 artigos e destes
12 foram incluídos no estudo. Conclusão: Foi evidenciada a importância da aplicação de um conjunto de medidas de controle de infecções
pelos profissionais da saúde para prevenir a infecção nesta população de pacientes.
Descritores: Diálise; Diálise renal/complicações; Infecções; Cateterismo venoso central/efeitos adversos
RESUMEN
Objetivo: Realizar una revisión sistemática sobre las medidas patronizadas para la prevención de infecciones relacionadas al catéter de
pacientes en hemodiálisis. Métodos: Fue realizada una revisión sobre la prevención de infecciones en hemodiálisis en las bases de datos
Medline, Embase, SciElo, Lilacs y Cochrane Library de estudios publicados entre los años de 1990 al 2008. Resultados: Fueron encontrados
293 artículos y de éstos 12 fueron incluidos en el estudio. Conclusión: Se evidenció la importancia de la aplicación de un conjunto de
medidas de control de infecciones por los profesionales de la salud para prevenir la infección en esta población de pacientes.
Descriptores: Diálisis; Diálisis renal/complicaciones; Infecciones; Cateterización venosa central/efectos adversos
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INTRODUCTION
Fourteen percent of  deaths among patients with end-
stage kidney disease (ESKD) are due to infections,
preceded only by cardiovascular diseases(1).
According to The United States Renal Data System
(USRDS), the number of patients receiving hemodialysis
in the United States of America (USA) was 328,000 in
2006(2). Data from Sociedade Brasileira de Nefrologia
(Brazilian Society of  Nephrology) reported that the
number of patients on dialysis treatment in Brazil was
73,605 in 2007 and 90.8% of those patients were receiving
hemodialysis(3).
Data from the USA National Healthcare Safety
Network demonstrated that bloodstream infection rates
in 2006 varied according to the site of vascular access:
0.5% arteriovenous fistula (AVF), 0.9% AV grafts, 4.2%
long-term central venous catheter and 27.1% short-term
central venous catheter per month, respectively. Most
microorganisms detected in the blood culture were
considered to be a skin contaminant coagulase-negative
Staphylococcus. Forty two percent (42%) of  Staphylococcus
aureus were resistant to methicillin and 39% of Enterococcus
spp were resistant to vancomycin(4).
Patients receiving hemodialysis have high risk for
infection due to immunosuppression caused by ESKD,
comorbidities, inadequate diet and the need for
maintaining the venous access for long periods. In dialysis
clinics many patients are submitted to this procedure at
the same time, leading to the dissemination of
microorganisms through direct or indirect contact with
the devices, equipment, contaminated surfaces or the hands
of  health professionals.
Microbial resistance should be considered because
patients on dialysis treatment are often hospitalized and
exposed to multi-resistant microorganisms and to broad-
spectrum antimicrobial therapy(5-7).
On the one hand, the quality of dialysis and thus
patients well being and survival depend on the venous
access; on the other hand, this is considered the major
risk factor for infection and especially bacteremia in this
group of patients(8).
In a study performed at Universidade Federal de São
Paulo, 61% of  patients with ESKD using central venous
catheter presented bacteremia. Risk factors for bacteremia
were: catheter insertion in the subclavian vein, duration
of catheter use and the hospitalization period. The
mortality rate in these patients was 29% and for patients
who developed endocarditis it was 55.5%(9).
As this population is exposed to a high infection risk
which can be prevented in most cases by health
professionals, a systematic review of literature was
performed to establish standard measures to prevent
catheter associated infections in hemodialysis patients.
EPIDEMIOLOGY
Twenty months of  epidemiological surveillance data
in the USA demonstrated that the risk for bacteremia
was 32 times higher when short-term venous catheter
was used, and 19 times higher when long-term venous
catheter was used compared to the use of arteriovenous
fistula (AVF). Similar data were observed in a study
conducted in 11 dialysis centers in Canada(10).
A prospective survey with 35,000 randomized patients
between the years of 1996 and 2007 treated in about 300
dialysis units in 12 countries demonstrated a great variation
on AVF utilization. AVF use declined in elderly, obese,
diabetic and patients with cardiovascular diseases or
recurrent cellulitis. Considering the high mortality caused
by the use of catheters, the best option for these patients
is AV graft. However, in some countries there was an
increase in catheter use and a proportional decrease in
the use of  AV grafts in patients with the characteristics
mentioned(11).
Measures to prevent catheter associated infections in
hemodialysis patients must be considered taking into
account the reduction in the use of central venous catheter
(CVC), giving priority to the use of  AVF whenever
possible. However, in patients with impaired vessels,
obesity and diabetes, where access through AVF or graft
can be difficult, long-term CVC use is recommended(8).
METHODS
The present study was carried out through a review
of the literature encompassing the issue of preventing
catheter-associated bloodstream infections in hemodialysis
patients. Studies published from 1990 to 2008 have been
selected through electronic search in the following
databases: Cochrane Library, Medline, SciELO, Embase, Lilacs,
works presented in congresses, reviews and guidelines.
The search strategy used for Medline presented the
following steps: Catheterization, Central Venous [Mesh]
AND Infection [Mesh]) AND Renal Dialysis [Mesh])
AND Renal Dialysis/education [Mesh] AND
Infection Control [Mesh]. To select articles, two
independent reviewers assessed the titles and abstracts of
the publications found. All studies in the issue meeting
the criteria for review have been included regardless of
the language or design. Photocopies of the articles have
been obtained and a standard form has been used to
extract data.
RESULTS
Two hundred and ninety three articles were found
according to the used descriptors, 50 of them were
literature reviews. After a previous selection, 12 studies
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that met the inclusion criteria were selected according to
the assessment of  the two independent reviewers. Four
of them were systematic reviews, two were prospective
cohorts, one was an experimental study, one was a meta-
analysis review, three were controlled randomized clinical
essays, and another one was a cross-sectional randomized
clinical trial. (Chart 1)
It was clear that surveillance is the essential issue for an
infection control program and also for improving quality
of care. A prospective study carried out in London between
2002 and 2004 with 112 patients (3418 patients per month)
demonstrated reduction in bacteremia rate from 6.2% to
2.0% per month, reduction in hospitalizations due to
bacteremia from 4.0% to 1.4% per month and also a
significant downward trend was seen in bacteremia rates
and antibiotic usage after the introduction of  a surveillance
scheme with patients risk stratification, definition of
denominators, type of  access performed by physicians and
nurses from the service, team training,  preventive measures
of infections, dissemination of data and use of results to
optimize the actions introduced(10).
The training and education of health professionals,
patients and care givers is recommended by the Center
for Disease Control and Prevention (CDC) to prevent
dialysis infections and must be compatible with the
available knowledge from the personnel involved(7). A
study conducted in a university hospital from São Paulo
demonstrated 40% reduction in catheter-associated
bloodstream infections (CABSI) after the implementation
of  an educational intervention with staff  members(12).
There are some standard precautions based on
strategies to prevent transmission of infections that health
professionals must use in patients care: hand washing
before and after the contact, use of gloves, masks,
protection glasses and laboratory coats when there is
risk of contact with biological material, be careful with
sharp-edged and hollow-pointed devices, environmental
cleaning, adequate use of materials and equipments and
health professionals immunization. When patients present
suspicion or confirmation of  a more severe infection,
additional measures must be taken in addition to those
mentioned above(13).
According to national and international
recommendations, catheter insertion has to be conducted
under sterile conditions and maximum barrier: masks,
laboratory coats, gloves and sterile drapes(7-8, 14).
Alcoholic chlorhexidine 2% (drug of choice) or
polyvinylpyrrolidone-iodine solution (PVP-I) 10% has
to be used for skin antisepsis before catheter insertion
and before dressing changes(7, 14). A randomized study(15)
highlighted that use of chlorhexidine before catheter
insertion and during dressing changes is associated with
less colonization and occurrence of CABSI when
compared to the use of alcoholic PVP-I.
Gauze or sterile transparent film are recommended
to dress the site of catheter insertion. After bathing or
showering it is important to inspect the insertion site,
protecting it and replacing the catheter-site dressing when
it becomes damp, loosened, or soiled(7-8, 14). A study(16)
demonstrated that mupirocin use in the catheter insertion
Chart 1  Summary of the studies included
 
Author, year of publication 
and country Design Participants Type of intervention 
George A, 2006- England Prospective cohort 112 patients Surveillance system 
Lobo RD, 2005- Brazil Experimental 75 professionals Health professional educational program 
Guideline CDC, 2001- USA Systematic review 206 references Recommendations for dialysis infection prevention 
Guideline CDC, 2007- USA Systematic review 1102 references Care Recommendations 
Guideline CDC, 2002- USA Systematic review 293 references Recommendations to prevent catheter-related infections 
Mimoz O, 2007- France 
Controlled 
randomized clinical 
trial 
538 catheters 
Use of chlorhexidine versus 
polyvinylpyrrolidone-iodine solution 
(PVP-I) 
Sesso R, 1998- Brazil 
Controlled 
randomized clinical 
trial 
136 patients Use of mupirocin on catheter insertion 
Johnson DW, 2002- Australia 
Controlled 
randomized clinical 
trial 
50 patients Use of mupirocin on catheter insertion 
Roth PE, 2006- Spain Cross-sectional 375 strains Mupirocin resistance 
Bleyer AJ, 2007- USA Systematic review 34 studies Use of antimicrobial lock solutions 
Safdar N, 2006- USA Systematic review with meta-analysis 7 studies 
Use of a vancomycin-lock solution to 
reduce bacteremia. 
Ethier J, 2008- multicenter Prospective cohort 35000 patients Venous access effectiveness 
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Another prevention strategy is the use of  gentamicin,
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In a meta-analysis, authors demonstrated that in high-
risk patients treated with long-term catheters the use of
vancomycin lock solution reduces the risk of
bacteremia(20).
CDC does not recommend the regular use of
antimicrobial lock solution to prevent bloodstream
infection. The use is recommended only in special
circumstances (e.g. patient with a long-term catheter or
patients with clinical data of recurrent infections despite
optimal maximal adherence to aseptic technique)(14).
CONCLUSION
Catheter-associated bloodstream infection can be
reduced when prevention measures are adequately taken
they are: proper choice of insertion site, local antisepsis,
personnel appropriate attire, infection surveillance, care
and maintenance of the catheter, as well as the use of
new technologies.
Taking into account that this is a population at high-
risk for infection, the emergence of multi-resistant
microorganisms must be considered, and if a severe
case occurs, additional prevention measures must be
taken to avoid an outbreak in this population.
All personnel involved in the process of catheter
insertion, maintenance and removal must be aware of
the importance of excellent care for infection prevention.
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